Consumer sleep technologies: what we know and what comes next Authors: Hannah Scott, Michael Grandner, Nicola Cellini Published: 2026 Consumer sleep technologies (CSTs) that quantify sleep in real-world settings are increasingly ubiquitous in modern society. Ranging from wearables to “nearables” and “airables,” these devices use a wide variety of sensing approaches and physiological monitoring techniques to estimate sleep and wakefulness and provide other useful information about physical activity, heart rate, breathing, and other health factors. Embraced by consumers, their uptake in research and clinical settings has been limited, largely due to uncertainties about performance and appropriate use cases. This special issue, summarized here, aimed to address this uncertainty by showcasing novel insights and applications of CST. Performance Evaluation Studies Three papers in this special issue directly address the question of how well CSTs measure sleep, and together they illustrate that accuracy is never a property of a device alone, but rather a property of a device in a specific population, under specific conditions, evaluated with specific methods. Lanthier and colleagues evaluated the Muse-S portable electroencephalography (EEG) headband against polysomnography (PSG) in 56 adults, including individuals with sleep-related breathing disorders [1]. The device achieved substantial overall epoch-by-epoch agreement, with near-perfect concordance for REM sleep and wake, and satisfactory agreement for NREM2 and NREM3. Performance was notably weaker for NREM1, a limitation which is shared with other portable EEG devices and, importantly, with human scorers themselves. These results position portable headband EEG as a serious candidate for accessible, multi-night, EEG-based sleep monitoring. Device-level performance figures can obscure important population-level variability. Searles et al. compared four devices (Fitbit Sense 2, Oura Ring 3rd Gen, Withings Sleep Mat, Sleep Score Max) against ambulatory PSG in healthy young (19–24 years) and older adults (56–80 years) [2]. Devices performed acceptably in younger adults but showed substantially greater bias, wider limits of agreement, and lower concordance in older adults across virtually all sleep metrics—most strikingly for “deep” sleep, which was overestimated by 70–97 min in the older group, depending on the device. These findings underscore a critical point: Algorithms trained and validated predominantly in young, healthy populations do not generalize to those most in need of sleep monitoring [3]. Finally, de Zambotti and colleagues highlight how methodological decisions such as epoch length mismatches, outdated firmware, and deviations from recommended wear conditions, systematically distort performance estimates, sometimes independently of any true device limitation [4]. Therefore, validation is not merely a question of which device, but of how the evaluation was conducted. Taken together, these papers reinforce the idea that CSTs of various types may be useful tools in sleep research and clinical practice, but that not all the CSTs are the same, and their performance evaluation should specify the device version, the population, the use conditions, and the analytical context [5, 6]. Dataset Considerations Two papers in this special issue clearly demonstrate why well-characterized datasets are important to enable transparent benchmarking and reproducible analyses. Sikder and colleagues present Wearanize+, a public, multimodal dataset combining synchronized PSG with multiple wearable and nearable devices [7]. Its value lies not only in scale, but in its methodological transparency, including clearly documented synchronization procedures, parallel manual, and automated scoring, and open access to curated data and code. This enables meaningful cross-device comparisons and supports independent replication. Canton and colleagues further show that dataset characteristics and evaluation choices can strongly influence reported model performance, often more so than model architecture itself [8]. Factors such as population composition and the proportion of easy-to-classify wake substantially altered performance estimates, highlighting the risks of interpreting results in isolation. These two contributions reinforce that the most effective way to advance CST research is through transparent reporting of rigorously described datasets to inform performance evaluation decisions. Application of CSTs Beyond performance evaluation, several papers in this special issue illustrate where CSTs are already delivering practical value. Taken together, they sketch a landscape of promising applications, though they also provide notes of caution for when the stakes are highest. Two papers address performance and symptom monitoring in real-world settings. Manners and colleagues demonstrate that sleep metrics derived from an under-mattress device can predict next-day vigilance, working memory, and mental arithmetic performance in a simulated shift-work protocol [9]. This suggests that passive, unobtrusive monitoring could inform determinations of cognitive readiness in occupational contexts. Complementing this, Fitton et al. show that a smartphone-based daily check-in approach can feasibly capture patient-reported outcomes over 6 months in individuals with suspected obstructive sleep apnea, with disease severity itself positively associated with sustained engagement [10]. This is an encouraging sign that those who need monitoring most may also be most motivated to maintain it. Two further papers look toward the future of behavioral and algorithmic intervention. Taylor et al. report high adherence and retention in sleep extension randomized controlled trials where participants used CSTs alongside personalized coaching [11]. This combination increased awareness and motivation, even as some users reported discomfort and emotional reactions to their data. Smith and colleagues go further, proposing that integrating wearable CSTs with artificial intelligence (specifically reinforcement learning and large language models) could enable just-in-time adaptive interventions tailored to the unpredictable schedules of non-standard-hours workers [12]. Both papers underscore that technology alone is insufficient: Human support and thoughtful implementation design are what convert data into behavior change. Finally, Devine and Hursh, in their narrative review of CSTs’ use in aviation, conclude that current devices have not been adequately validated for the in-flight environment, despite the appeal of ecological fatigue monitoring for flight crew [13]. In a safety-critical industry where fatigue management carries regulatory weight, this gap matters. Taken together, these studies indicate that CSTs perform well in contexts for which they were designed, and they also have utility in other settings where they have proven value (e.g. vigilance-relevant work; symptom monitoring). They also show, though, that the technology requires continued improvement for high-stakes applications, where errors can harm (e.g. flight deck fatigue). Human-in-the-loop beats black-box-in-the-wild. Five Key Takeaways from this Special Issue Clear documentation of device and data characteristics should be understood as a practical aid to interpretation rather than a demand for full algorithmic transparency. Contributions in this special issue illustrate how methodological choices (e.g. epoch length, wear conditions) shape CST performance and downstream interpretation. These factors interact with device firmware, software, and cloud-level processing, all of which may evolve over the lifespan of a study. Historically, such details have been inconsistently reported, reflecting disciplinary norms and rapid technological iteration rather than insufficient rigor. Crucially, incomplete visibility into proprietary algorithms does not preclude meaningful application of CST data. As with many medical technologies, some tolerance for “black box” processing is both inevitable and acceptable, provided performance is empirically evaluated and characterized in the relevant population and context. This expands the question of “Is the device accurate?” to “When and where is the device accurate, and how do I interpret results in a range of contexts?” Clear documentation of device and data characteristics should be understood as a practical aid to interpretation rather than a demand for full algorithmic transparency. Contributions in this special issue illustrate how methodological choices (e.g. epoch length, wear conditions) shape CST performance and downstream interpretation. These factors interact with device firmware, software, and cloud-level processing, all of which may evolve over the lifespan of a study. Historically, such details have been inconsistently reported, reflecting disciplinary norms and rapid technological iteration rather than insufficient rigor. Crucially, incomplete visibility into proprietary algorithms does not preclude meaningful application of CST data. As with many medical technologies, some tolerance for “black box” processing is both inevitable and acceptable, provided performance is empirically evaluated and characterized in the relevant population and context. This expands the question of “Is the device accurate?” to “When and where is the device accurate, and how do I interpret results in a range of contexts?” Most commercial sleep algorithms have been trained in relatively healthy, middle-aged adults, for whom many devices will inevitably perform well (detecting sleep when sleep is highly likely is a rather simple task). However, physiological signals and their relationship to sleep vary systematically across the lifespan and with health status. This reinforces the need for well-described and stratified performance evaluation reporting, and careful claims about generalizability. Most commercial sleep algorithms have been trained in relatively healthy, middle-aged adults, for whom many devices will inevitably perform well (detecting sleep when sleep is highly likely is a rather simple task). However, physiological signals and their relationship to sleep vary systematically across the lifespan and with health status. This reinforces the need for well-described and stratified performance evaluation reporting, and careful claims about generalizability. Treating CSTs as interchangeable or generic instruments ignores evidence that their performance is intrinsically tied to context. Devices differ in sensor composition and quality, signal processing pipelines, and algorithm design, leading to predictable strengths and limitations depending on the outcome of interest, population, and context of use. As demonstrated across studies in this special issue, no single CST performs optimally across all sleep metrics, scenarios, or populations—nor should this be expected. Meaningful evaluation and implementation therefore require clearly specified intended uses, with device selection guided by evidence of adequate performance for the variables of interest, in the populations of interest. Treating CSTs as interchangeable or generic instruments ignores evidence that their performance is intrinsically tied to context. Devices differ in sensor composition and quality, signal processing pipelines, and algorithm design, leading to predictable strengths and limitations depending on the outcome of interest, population, and context of use. As demonstrated across studies in this special issue, no single CST performs optimally across all sleep metrics, scenarios, or populations—nor should this be expected. Meaningful evaluation and implementation therefore require clearly specified intended uses, with device selection guided by evidence of adequate performance for the variables of interest, in the populations of interest. Ecological validation should be a priority for CST research and implementation. While in-laboratory PSG comparisons remain an informative, gold-standard first step, they are insufficient to characterize performance under typical conditions of use. Meaningful applications require evaluation across real world variability. Several studies in this special issue discuss both the potential and constraints of CSTs in operational contexts such as shift work, aviation, and long-term home monitoring. Together, these findings reflect a necessary shift toward in situ testing, where robustness, feasibility, and longitudinal consistency are critical, and where the real-world value of CSTs can be meaningfully assessed. Ecological validation should be a priority for CST research and implementation. While in-laboratory PSG comparisons remain an informative, gold-standard first step, they are insufficient to characterize performance under typical conditions of use. Meaningful applications require evaluation across real world variability. Several studies in this special issue discuss both the potential and constraints of CSTs in operational contexts such as shift work, aviation, and long-term home monitoring. Together, these findings reflect a necessary shift toward in situ testing, where robustness, feasibility, and longitudinal consistency are critical, and where the real-world value of CSTs can be meaningfully assessed. CST implementation must be aligned with context of use and associated risk. Most devices are designed for longitudinal, self-directed monitoring and perform best in this role. Safety-critical and clinical applications require sector-specific validation frameworks and clearly defined thresholds for acceptable error. As evidence and standards evolve [14], integration may increase, but context, risk profile, and regulatory requirements should remain the primary determinants of deployment. CST implementation must be aligned with context of use and associated risk. Most devices are designed for longitudinal, self-directed monitoring and perform best in this role. Safety-critical and clinical applications require sector-specific validation frameworks and clearly defined thresholds for acceptable error. As evidence and standards evolve [14], integration may increase, but context, risk profile, and regulatory requirements should remain the primary determinants of deployment. This special issue demonstrates that CSTs are useful tools for research, already delivering practical value in several domains. The pathway to broader trust and clinical or operational integration now lies in its evaluation in context, with transparent and full reporting of population and contextual factors essential to assess performance and utility. This is a special collection article Consumer Sleep Technology. Contributor Information Hannah Scott, Flinders Health and Medical Research Institute: Sleep Health, Flinders University, Adelaide, Australia. Michael Grandner, Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson, AZ, United States. Nicola Cellini, Department of General Psychology, University of Padova, Padova, Italy. Author contributions Hannah Scott (Conceptualization [equal], Writing—original draft [equal], Writing—review & editing [equal]), Michael A. Grandner (Conceptualization [equal], Writing—review & editing [supporting]), Nicola Cellini (Conceptualization [equal], Writing—original draft [equal], Writing—review & editing [equal]) Funding H.S. is funded by a National Health and Medical Research Council of Australia Investigator Grant (2041434). Disclosure statement Financial disclosure: H.S. reports a patent for a method of sleep monitoring and control. H.S. also reports consultancy and/or research support unrelated to this work from Re-Time Pty Ltd, Compumedics Ltd, the American Academy of Sleep Medicine Foundation, and Flinders University. H.S. is funded by a National Health and Medical Research Council of Australia Investigator Grant (2041434). M.G. reports receiving personal fees from Google, Vytalogy, Haleon, Kenvue, Smartypants Vitamins, and WNDR HLTH; and grants from Harmony Viosciences outside the submitted work. N.C. has no conflicts of interests to disclose. Non-financial disclosure: None declared. References